Steatocystoma multiplex-natal teeth syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3184OMIM:184510L72.2
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Steatocystoma multiplex-natal teeth syndrome is an extremely rare genetic disorder characterized by the combination of steatocystoma multiplex (multiple sebaceous cysts of the skin) and natal teeth (teeth present at birth). Steatocystoma multiplex involves the development of numerous small, smooth, yellowish or skin-colored cystic nodules in the skin, typically located on the trunk, arms, and other areas rich in sebaceous glands. These cysts are filled with an oily or creamy substance derived from sebaceous glands. Natal teeth, which are teeth already erupted at the time of birth, represent the other hallmark feature of this syndrome. The condition primarily affects the skin (integumentary system) and the dental/oral system. This syndrome has been reported in a very limited number of families in the medical literature. The steatocystomas typically become more apparent during adolescence or early adulthood, while the natal teeth are evident at birth. The natal teeth may be loose and may require extraction to prevent aspiration risk in the newborn. Additional features that have been reported in some cases include pachyonychia (thickened nails) and other ectodermal abnormalities. The condition has been linked to mutations in the KRT17 gene, which encodes keratin 17, a protein important in the development of skin appendages, hair follicles, and nails. This places the syndrome within the spectrum of keratin disorders related to pachyonychia congenita. Treatment is primarily symptomatic and supportive. Management of steatocystomas may include surgical excision, incision and drainage, or laser therapy for cosmetically bothersome cysts. Natal teeth are managed by a pediatric dentist, with extraction considered if they are supernumerary or pose a risk of aspiration. There is currently no cure for the underlying genetic condition, and long-term follow-up with dermatology is recommended for ongoing management of skin cysts.

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Nov 1992

Alkeran For Injection: FDA approved

For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate.

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Alkeran For Injection

Melphalan· Glaxo Wellcome Inc.■ Boxed WarningOrphan Drug

For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate.

No actively recruiting trials found for Steatocystoma multiplex-natal teeth syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Steatocystoma multiplex-natal teeth syndrome community →

No specialists are currently listed for Steatocystoma multiplex-natal teeth syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Steatocystoma multiplex-natal teeth syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Steatocystoma multiplex-natal teeth syndromeForum →

No community posts yet. Be the first to share your experience with Steatocystoma multiplex-natal teeth syndrome.

Start the conversation →

Latest news about Steatocystoma multiplex-natal teeth syndrome

No recent news articles for Steatocystoma multiplex-natal teeth syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Steatocystoma multiplex-natal teeth syndrome

What is Steatocystoma multiplex-natal teeth syndrome?

Steatocystoma multiplex-natal teeth syndrome is an extremely rare genetic disorder characterized by the combination of steatocystoma multiplex (multiple sebaceous cysts of the skin) and natal teeth (teeth present at birth). Steatocystoma multiplex involves the development of numerous small, smooth, yellowish or skin-colored cystic nodules in the skin, typically located on the trunk, arms, and other areas rich in sebaceous glands. These cysts are filled with an oily or creamy substance derived from sebaceous glands. Natal teeth, which are teeth already erupted at the time of birth, represent th

How is Steatocystoma multiplex-natal teeth syndrome inherited?

Steatocystoma multiplex-natal teeth syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Steatocystoma multiplex-natal teeth syndrome typically begin?

Typical onset of Steatocystoma multiplex-natal teeth syndrome is neonatal. Age of onset can vary across affected individuals.

What treatment and support options exist for Steatocystoma multiplex-natal teeth syndrome?

1 patient support program are currently tracked on UniteRare for Steatocystoma multiplex-natal teeth syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.